Injectable anthracycline antibiotic formulation for treating acute myeloid leukemia and other hematologic malignancies. Supplied by pharmaceutical manufacturers to oncology units in hospitals and cancer treatment facilities for intravenous administration by oncologists and hematologists in clinical protocols.